Participants 45 78 6
patients with chronic hepatitis C
Participants 300 333 7
patients with chronic hepatitis C
Participants 410 418 3
PATIENTS
Participants 514 557 8
untreated patients with chronic hepatitis C
Participants 953 1001 5
patients in the control and the amantadine group
Participants 1016 1058 4
control group but not the amantadine group
